Sepsim

Sepsim is a breakthrough biotech company developing a novel drug to combat Sepsis and MRSA—two of the deadliest threats in modern medicine. In preclinical animal trials, the results were nothing short of extraordinary: 100% survival in treated subjects, compared to 100% mortality in untreated controls. Our mission is clear and urgent: to solve Sepsis, a condition that claims millions of lives each year with limited effective treatments available. At Sepsim, we believe the cure starts here.